These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 25119962

  • 1. Effects of subconjunctival tocilizumab versus bevacizumab in treatment of corneal neovascularization in rabbits.
    Yoo AR, Chung SK.
    Cornea; 2014 Oct; 33(10):1088-94. PubMed ID: 25119962
    [Abstract] [Full Text] [Related]

  • 2. Comparative study of tacrolimus and bevacizumab on corneal neovascularization in rabbits.
    Park JH, Joo CK, Chung SK.
    Cornea; 2015 Apr; 34(4):449-55. PubMed ID: 25651492
    [Abstract] [Full Text] [Related]

  • 3. The effect of subconjunctival suramin on corneal neovascularization in rabbits.
    Lee HS, Chung SK.
    Cornea; 2010 Jan; 29(1):86-92. PubMed ID: 19907290
    [Abstract] [Full Text] [Related]

  • 4. The effect of subconjuctival combined treatment of bevacizumab and triamcinolone acetonide on corneal neovascularization in rabbits.
    Kang S, Chung SK.
    Cornea; 2010 Feb; 29(2):192-6. PubMed ID: 20098156
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin).
    Kim TI, Kim SW, Kim S, Kim T, Kim EK.
    Cornea; 2008 Apr; 27(3):349-52. PubMed ID: 18362666
    [Abstract] [Full Text] [Related]

  • 6. Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis.
    Chen WL, Lin CT, Lin NT, Tu IH, Li JW, Chow LP, Liu KR, Hu FR.
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1659-65. PubMed ID: 18997093
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of corneal neovascularization by subconjunctival and topical bevacizumab and sunitinib in a rabbit model.
    Ko BY, Kim YS, Baek SG, Lee GW, Kim JM, Jean WS, Lee NS, Kang J.
    Cornea; 2013 May; 32(5):689-95. PubMed ID: 23377751
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model.
    Papathanassiou M, Theodossiadis PG, Liarakos VS, Rouvas A, Giamarellos-Bourboulis EJ, Vergados IA.
    Am J Ophthalmol; 2008 Mar; 145(3):424-431. PubMed ID: 18207123
    [Abstract] [Full Text] [Related]

  • 9. Comparative study of ranibizumab and bevacizumab on corneal neovascularization in rabbits.
    Kim EK, Kong SJ, Chung SK.
    Cornea; 2014 Jan; 33(1):60-4. PubMed ID: 24240485
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory Effect of Topical Aflibercept on Corneal Neovascularization in Rabbits.
    Park YR, Chung SK.
    Cornea; 2015 Oct; 34(10):1303-7. PubMed ID: 26114826
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of subconjunctival bevacizumab (Avastin) on experimental corneal neovascularization in guinea pigs.
    Hurmeric V, Mumcuoglu T, Erdurman C, Kurt B, Dagli O, Durukan AH.
    Cornea; 2008 Apr; 27(3):357-62. PubMed ID: 18362668
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of bevacizumab on corneal neovascularization in experimental rabbit model.
    Ahmed A, Berati H, Nalan A, Aylin S.
    Clin Exp Ophthalmol; 2009 Sep; 37(7):730-6. PubMed ID: 19788671
    [Abstract] [Full Text] [Related]

  • 16. Clinico-biochemical correlation of the effect of subconjunctival bevacizumab for corneal neovascularization.
    Agarwal S, Angayarkanni N, Iyer G, Srinivasan B, Natarajan R, Charola S, Arumugam S, Padmanabhan P.
    Cornea; 2014 Oct; 33(10):1016-21. PubMed ID: 25090164
    [Abstract] [Full Text] [Related]

  • 17. Prevention and treatment of corneal neovascularization: comparison of different doses of subconjunctival bevacizumab with corticosteroid in experimental rats.
    Hashemian MN, Moghimi S, Kiumehr S, Riazi M, Amoli FA.
    Ophthalmic Res; 2009 Oct; 42(2):90-5. PubMed ID: 19546599
    [Abstract] [Full Text] [Related]

  • 18. Effect of subconjunctival and intraocular bevacizumab injections on corneal neovascularization in a mouse model.
    Avisar I, Weinberger D, Kremer I.
    Curr Eye Res; 2010 Feb; 35(2):108-15. PubMed ID: 20136420
    [Abstract] [Full Text] [Related]

  • 19. The effect of bevacizumab on corneal neovascularization in rabbits.
    Kim WJ, Jeong HO, Chung SK.
    Korean J Ophthalmol; 2010 Aug; 24(4):230-6. PubMed ID: 20714387
    [Abstract] [Full Text] [Related]

  • 20. Bevacizumab inhibits corneal neovascularization in an alkali burn induced model of corneal angiogenesis.
    Hosseini H, Nejabat M, Mehryar M, Yazdchi T, Sedaghat A, Noori F.
    Clin Exp Ophthalmol; 2007 Nov; 35(8):745-8. PubMed ID: 17997779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.